1 Min Read
Dec 14 (Reuters) - Syndax Pharmaceuticals Inc
* Syndax Pharmaceuticals announces collaboration with the National Cancer Institute to develop entinostat and SNDX-6352 for the treatment of cancer Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.